Regeneron Pharmaceuticals shares owned by Fagan Associates
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Fagan Associates
from 13F filings
Historical chart of Fagan Associates investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Fagan Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Fagan Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.7M | 8.7k | 878.29 |
| 2023-09-30 | $7.1M | 8.6k | 822.96 |
| 2023-06-30 | $6.0M | 8.3k | 718.54 |
| 2023-03-31 | $6.7M | 8.1k | 821.67 |
| 2022-12-31 | $5.7M | 8.0k | 721.50 |
| 2022-09-30 | $5.6M | 8.1k | 688.91 |
| 2022-06-30 | $4.8M | 8.1k | 591.19 |
| 2022-03-31 | $5.7M | 8.1k | 698.43 |
| 2021-12-31 | $5.0M | 7.9k | 631.58 |
| 2021-09-30 | $4.7M | 7.7k | 605.16 |
| 2021-06-30 | $4.3M | 7.7k | 558.54 |
| 2021-03-31 | $3.5M | 7.5k | 473.16 |
| 2020-12-31 | $3.3M | 6.8k | 483.08 |
| 2020-09-30 | $3.5M | 6.3k | 559.78 |
| 2020-06-30 | $3.6M | 5.7k | 623.71 |
| 2020-03-31 | $2.8M | 5.7k | 488.34 |
| 2019-12-31 | $209k | 557 | 375.22 |
| 2019-03-31 | $2.3M | 550 | 4109.09 |
| 2018-12-31 | $205k | 550 | 372.73 |
| 2018-09-30 | $222k | 550 | 403.64 |
| 2018-06-30 | $209k | 605 | 345.45 |
| 2018-03-31 | $208k | 605 | 343.80 |
| 2017-12-31 | $227k | 605 | 375.21 |
| 2017-09-30 | $1.5M | 3.3k | 447.26 |
| 2017-06-30 | $1.5M | 3.1k | 491.17 |
| 2017-03-31 | $1.1M | 2.9k | 387.68 |
| 2016-12-31 | $1.0M | 2.8k | 367.20 |
| 2016-09-30 | $710k | 1.8k | 402.27 |
| 2016-06-30 | $286k | 820 | 348.78 |
| 2016-03-31 | $288k | 800 | 360.00 |
| 2015-12-31 | $440k | 810 | 543.21 |
| 2015-09-30 | $342k | 735 | 465.31 |
| 2015-06-30 | $367k | 720 | 509.72 |
| 2015-03-31 | $332k | 735 | 451.70 |
| 2014-12-31 | $357k | 870 | 410.34 |
| 2014-09-30 | $314k | 870 | 360.92 |
| 2014-06-30 | $246k | 870 | 282.76 |
| 2014-03-31 | $251k | 835 | 300.60 |